Manager × security

SIG BROKERAGE, LP VRTX holdings history

Who else holds this security? →

VERTEX PHARMACEUTICALS INC · CUSIP 92532F100 · CIK 1094429

Citable facts

As of Sep 30, 2026, SIG BROKERAGE, LP reported 24.30K VRTX (shares), valued at $12.70M, or 1.73% of its reported non-derivative portfolio. Filed Nov 16, 2026.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
1.73%
Shares
24.30K
24,295
Reported value
$12.70M
USD

Shares increased 8.51%; reported value increased 14.21%, and weight changed -0.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q3 20261.73%24,295SEC filing ↗Filed Nov 16, 2026
Q2 20261.78%22,390SEC filing ↗Filed Aug 14, 2026
Q1 20262.22%17,605SEC filing ↗Filed May 15, 2026
Q4 20253.18%20,864SEC filing ↗Filed Feb 17, 2026
Q3 20252.60%26,390SEC filing ↗Filed Nov 14, 2025
Q2 20253.98%32,566SEC filing ↗Filed Aug 14, 2025
Q1 20250.16%1,120SEC filing ↗Filed May 14, 2025
Q4 20240.37%1,938SEC filing ↗Filed Feb 14, 2025
Q3 2024Not reportedNot reportedNo filing this quarter
Q2 2024Not reportedNot reportedNo filing this quarter
Q1 2024Not reportedNot reportedNo filing this quarter
Q4 2023Not reportedNot reportedNo filing this quarter

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 2023Not reported——The manager filed nothing for this quarter; a missing quarter is not treated as zero holdings.—
Q1 2024Not reported——The manager filed nothing for this quarter; a missing quarter is not treated as zero holdings.—
Q2 2024Not reported——The manager filed nothing for this quarter; a missing quarter is not treated as zero holdings.—
Q3 2024Not reported——The manager filed nothing for this quarter; a missing quarter is not treated as zero holdings.—
Q4 20240.37%1,938$780.43KA comparable prior-quarter record is unavailable; changes are not inferred.SEC filing ↗
Filed Feb 14, 2025
Q1 20250.16%1,120$543.00KShares decreased 42.21%; reported value decreased 30.42%, and weight changed -0.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2025
Q2 20253.98%32,566$14.50MShares increased 2,807.68%; reported value increased 2,570.06%, and weight changed +3.82 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20252.60%26,390$10.34MShares decreased 18.96%; reported value decreased 28.71%, and weight changed -1.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20253.18%20,864$9.46MShares decreased 20.94%; reported value decreased 8.48%, and weight changed +0.58 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20262.22%17,605$7.86MShares decreased 15.62%; reported value decreased 16.89%, and weight changed -0.96 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20261.78%22,390$11.12MShares increased 27.18%; reported value increased 41.47%, and weight changed -0.44 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Q3 20261.73%24,295$12.70MShares increased 8.51%; reported value increased 14.21%, and weight changed -0.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 16, 2026
SIG BROKERAGE, LP · VERTEX PHARMACEUTICALS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_institutional_holdings
{"action":"portfolio","cik":"1094429","quarter":"2026Q3","cusip":"92532F100"}

akkru_institutional_holdings
{"action":"history","cik":"1094429","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP / CLI documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.